EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China Pioneer Pharma Holdings, Limited (HK Stock Code:1345), a leading marketer of branded pharmaceutical products and medical devices in China, has placed its first order for NovaBay’s NeutroPhase® Skin and Wound Cleanser. NovaBay will be shipping NeutroPhase to China later this year to support Pioneer’s launch of the product in early 2015 throughout mainland China.
Help employers find you! Check out all the jobs and post your resume.
